MAIA Biotechnology, Inc., ("MAIA", the "Company"), a clinical-stage biopharmaceutical company developing targeted immunotherapies for cancer, today announced that an abstract detailing a potential ...
Linus Health will deliver poster presentations at AD/PD from two clinical studies evaluating the accuracy, efficacy, and ...
Noul Co., Ltd. a Korea-based medical AI company, announced that it presented a poster titled "Bridging Medical Gaps from ...
LUND, SE / ACCESS Newswire / March 21, 2025 / BioInvent International AB ("BioInvent") (Nasdaq Stockholm:BINV), a biotech company focused on the discovery and development of novel and first-in-class i ...
LUND, SE / ACCESS Newswire / March 21, 2025 / BioInvent International AB ("BioInvent") , a biotech company focused on the discovery and development of novel and first-in-class immune-modulatory ...
Bailey and Trevor Herbstritt, 16-year-old twins from Kersey, are juniors at St. Marys Area High School and second-year ...
From June 12–13 , 2025, the 3rd Advances in Separation Science Workshop will take take place in Gembloux, Belgium.
Opinion
5dOpinion
allAfrica.com on MSN‘Fund research not Tesla trucks’: The HIV casualties of Trump’s war on scienceThere were empty seats in San Francisco last week at an annual international science conference that has delivered some of the world’s most groundbreaking HIV research. It was a throwback to another ...
6dOpinion
Daily Maverick on MSNThe HIV casualties of Trump’s war on scienceThere were empty seats in San Francisco last week at an annual international science conference which has delivered some of ...
As part of our broader growth strategy, IR-MED is actively working toward uplisting to the Nasdaq Stock Exchange, a move that we believe will enhance shareholder value and expand our reach among ...
Presentations will feature potential best-in-class pan-RAS molecular glue ERAS-0015 and pan-KRAS inhibitor ERAS-4001Erasca will also present ...
Cogent Biosciences, Inc. (Nasdaq: COGT), a biotechnology company focused on developing precision therapies for genetically defined diseases, today announced four preclinical poster presentations at ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results